Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

ABSTRACT: A multi-center, non-random, open study ,to observe efficacy and safety of bevacizumab plus Oxaliplatin based multidrug chemotherapy as conversion therapy for patients with previously untreated unresectable liver metastases from colorectal cancer.

DISEASE(S): Neoplasm Metastasis,Liver Metastases,Colorectal Cancer,Colorectal Neoplasms,Liver Neoplasms

PROVIDER: 2137916 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR